IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Predictions For The Future Of Antimicrobial Stewardship

Antimicrobial stewardship is becoming integrated into healthcare systems and is here to stay. But what does the future hold? Learn here from insight provided by a seasoned antimicrobial steward.


antimicrobial stewardship predictions



Debra Goff

Authored By: Debra A. Goff, Pharm.D., FCCP


[Last updated: 8 June 2016]

In over 30 years of practice as an infectious diseases (ID) clinical pharmacist, I cannot think of a more exciting time to be in the field of ID and antimicrobial stewardship.

There is always new ID breaking news requiring us to stay on top of our game. It seems like there should be a “bug of the month” club for clinicians that would describe new multidrug resistant organisms and propose how to approach the next antibiotic treatment.

It’s hard enough for ID experts to stay on top of what I call the “alphabet soup” of antibiotic resistance (e.g., KPC, ESBL, NDM-1, CRE, MCR-1). How can we expect non-ID clinicians to understand all this new resistance to antibiotics? This is why healthcare needs antimicrobial stewardship programs (ASPs). ASP pharmacists, physicians and team members have a golden opportunity. The sky’s the limit in my mind if we allow ourselves to seize the moment.

Here, I identify four areas that I believe hold the key to the future for ASPs.

1. Rapid diagnostic tests (RDTs)

These are the game changers in infectious diseases. Just like our cardiology colleagues who coined the phrase “door to balloon, time is muscle” in the management of patients with acute myocardial infarction, antimicrobial stewards should coin the phrase “door to effective antibiotic, time is lives saved.”

We can no longer afford to wait 3-4 days to know the organism and susceptibility. RDT just makes sense and the studies all tell the same story. The faster we know the organism and resistance markers or susceptibilities, the faster patients receive effective antibiotics.

It’s amazing to think that there is technology that allows direct from blood to diagnose candidemia in hours without waiting for growth from a blood culture bottle! It’s the star wars of RDT. Stay tune on RDT. I believe they will be the standard of care in all healthcare settings.

2. Qualifications to prescribe antimicrobials

The decades of passing out antibiotics like candy have finally caught up with the world. Back in the good old days we needed the “antibiotic of the month” club just to keep up with all the new “cephalosomethings” and “quinolonagain” antibiotics. Times have changed as the world runs out of effective antibiotics. This requires a reassessment of not only how we prescribe antibiotics but who prescribes antibiotics.

ASPs could propose to follow the oncology model (only oncologists can prescribe chemotherapy) and have only ID physicians prescribe antibiotics, however it is not realistic. In 2016 58% of ID physician training programs went unfilled. The shortage of ID physicians will continue to grow.

It has been proposed to educate or test physicians on antibiotics when they start working at a new hospital. Demonstrating the ability to pass an antibiotic test does not mean the clinician can apply the knowledge at the bedside of a patient. Many antibiotics are prescribed “just-in-case” there’s an infection. I call it living in the moment (the patient in front of me today is who I care about) with disregard for future consequences (antimicrobial resistance).

ASP pharmacists and physicians will play a role in overseeing antibiotics but the thought of having ASP approve every antibiotic would create a thankless job. I think the EHR systems need to provide meaningful help. Currently prescribers in some EHR systems can check any reason for prescribing antibiotics, without consequences. For example if the system asks if the antibiotic is for prophylaxis, empiric, or therapeutic the prescriber can click on any one of the three knowing no one confirms the accuracy of their choice. How does this help curtail inappropriate antibiotic use? It doesn’t, it just fulfills a proposed Centers for Medicare & Medicaid Services criteria for ASP.

I think ASP’s need to lobby hard for better support from EHR to assist in meaningful antibiotic indications for use and bug-drug mismatches. Automatic weekly feedback to prescribers benchmarking their antibiotic use against their peers is the best shot at changing behavior.

3. Outreach and Engagement

Every superbug is just a plane ride away. This requires ASPs to function as one world. The internet and social media (Twitter, Instagram, Facebook,) provides opportunities to engage with thought leaders, colleagues, consumers, and patient advocate groups just to name a few.

Surgeons and oncologist are some of the highest users of antibiotics and often the most difficult to engage in ASPs. I haven’t found many of them reading the current issue of any ID journal so how can I expect them to know the latest antibiotic resistance issue? Guess what, you can find them on social media! I have met, engaged, and collaborated in research with some of the most interesting people on Twitter. Try following some surgeons and oncologists on Twitter. Tweet ID topics of interest to them and they will engage with you. Instagram is an example of a novel way to educate and engage people in ID and antimicrobial stewardship. Social media is a great way to stay engaged with ASP global advocates. You can teach the world, it’s powerful.

Community outreach is also a social obligation of ASPs. Until consumers learn that antibiotics are a precious resource that should not be abused, consumers will continue to pressure doctors to prescribe them. Who better than an ASP pharmacist or physician to talk to grade school, high school, or college students about responsible use of antibiotics? Co-create a YouTube video to engage them in the topic, for example. If we make learning fun people will listen.

4. Research and Publication

Antibiotics are societal drugs and ASPs have been called upon to help society address antimicrobial resistance. ASP research in peer reviewed ID journals is necessary, however this will not engage or inform non-ID colleagues or consumers.

Since we are all working towards the same goal of improving the responsible use of antimicrobials and decreasing antimicrobial resistance, we should collaborate and publish more often in each others journals. In addition to traditional journal publications other avenues should be explored such as blogs and websites. Blogs allow for more creative writing and often reflect personal experience from thought leaders or up and coming future leaders.

In summary, antimicrobial stewardship is evolving, with a bright future ahead. It will be required soon in all healthcare settings and that creates amazing opportunities for pharmacists and physicians.

I never want ASPs viewed as the cost-savings restricting antimicrobial program. If we are smart we will be viewed as the protector of a precious resource called antimicrobials. Responsible use will impact patient care and that’s why we do what we do.


If you liked this article you may also like:

antimicrobial stewardship insights


 

Filed Under: Infectious Diseases & Antimicrobial Stewardship Tagged With: antimicrobial stewardship, Infectious Disease

LEARN ANTIBIOTICS

Paperback Book

Let’s Talk Micro

STEWARD PINS

Subscribe

Sign up for the monthly newsletter!

We will never spam you. We want you to like us. By clicking the Subscribe button, you accept the Terms of Service and Privacy Policy.

Categories

  • COVID-19
  • Healthcare At Large
  • Infectious Diseases & Antimicrobial Stewardship
  • Pharmacy News
  • Reality Check
  • Residency & Training
  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Tumblr
  • Twitter
  • YouTube

Recent Posts

  • Pharmacy Student Study Strategies To Maximizing Learning In 2025 And Beyond
  • 5 Things To Know About Interpreting MRSA Nares Swab Results
  • Five Tidbits From The Largest International Meeting Of Clinical Microbiologists & Infectious Diseases Specialists In 2025
  • Five Things For Pharmacists To Know About Measles in 2025
  • 5 Things You Need To Know About The Learn Antibiotics Book Of Games

More Articles

Something Cool & Something Lame With 5 Antibiotics

Something Cool & Something Lame With 5 Antibiotics

5 Neat Things From The World Of Antimicrobials

5 Neat Things From The World Of Antimicrobials

5 Instances Of Challenging Antibiotic Workflows

5 Instances Of Challenging Antibiotic Workflows

Advice For New Pharmacy Interns: A White Coat Ceremony Key Note Speech

Advice For New Pharmacy Interns: A White Coat Ceremony Key Note Speech

Tags

antibiotic Antibiotics antimicrobial stewardship bcps beta-lactam cancer Chemotherapy Clinical Controversies clinical pharmacist clinical pharmacy community pharmacist Critical Care emergency medicine Emoji Game fellowship figure1 Hepatitis C hospital pharmacist hospital pharmacy Infectious Disease infectious diseases Lifestyle MRSA NAPLEX Natural Disaster oncology pharmacist one-on-one penicillin allergy PGY2 pharmacy fellowship Pharmacy Job pharmacy practice pharmacy residency pharmacy school pharmacy student Pharmacy technician PK-PD Compass Predatory Journals Rapid Diagnostic Testing residency social media student pharmacist study table transplant Zika

Recent

  • Pharmacy Student Study Strategies To Maximizing Learning In 2025 And Beyond
  • 5 Things To Know About Interpreting MRSA Nares Swab Results
  • Five Tidbits From The Largest International Meeting Of Clinical Microbiologists & Infectious Diseases Specialists In 2025
  • Five Things For Pharmacists To Know About Measles in 2025
  • 5 Things You Need To Know About The Learn Antibiotics Book Of Games

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact